We have detected that you are using Internet Explorer to visit this website. Internet Explorer is now being phased out by Microsoft. As a result, NHS Digital no longer supports any version of Internet Explorer for our web-based products, as it involves considerable extra effort and expense, which cannot be justified from public funds. Some features on this site will not work. You should use a modern browser such as Edge, Chrome, Firefox, or Safari. If you have difficulty installing or accessing a different browser, contact your IT support team.
Prescribing for Diabetes in England - 2005/06 to 2014/15Official statistics
- Publication Date:
- 12 Aug 2015
- Geographic Coverage:
- Geographical Granularity:
- Country, Primary Care Trusts, Clinical Commissioning Groups, Primary Care Organisations
- Date Range:
- 01 Apr 2005 to 31 Mar 2015
This report shows prescribing trends for medicines prescribed in primary care in England for the treatment of diabetes for the period April 2005 to March 2015.
This is the latest in a series of annual reports published by the Health and Social Care Information Centre (HSCIC) on Prescribing for Diabetes in England, within primary care.
Diabetes is a high profile clinical area, as the prevalence is increasing and costs associated with treating patients with diabetes are also increasing.
Note: The last sentence of the second bullet point on page 4 in the Executive Summary has been corrected as at 14th August 2015 to show the total cost of prescribing for diabetes in 2005/06 as £513.9million.
The csv file has been corrected as at 1st September 2015 to replace organisation codes that were corrupted as part of the update on the 14th August.
We apologise for any inconvenience caused.
- In 2014/15 there were 47.2 million items prescribed for diabetes (BNF section 6.1) at a net ingredient cost of £868.6 million.
- In 2014/15 Prescribing for diabetes accounted for 4.5 per cent of total items prescribed and 10.0 per cent of the total cost of all prescribing.
- In 2014/15 there were 6.7 million items of insulin prescribed (BNF 6.1.1), at a net ingredient cost of £334.7 million.
- In 2014/15 there were 33.4 million items prescribed for Antidiabetic drugs (BNF 6.1.2), representing 70.8 per cent of all items for diabetes, at a net ingredient cost of £350.2 million.
- Since 2005/06, Antidiabetic drugs items prescribed have increased by 107.0 per cent and net ingredient cost by 138.6 per cent.
NHS BSA, Quality and Outcomes Framework,ePACT, QOF, NDA